BR0317748A - Compound, pharmaceutical composition, and use of a compound - Google Patents

Compound, pharmaceutical composition, and use of a compound

Info

Publication number
BR0317748A
BR0317748A BR0317748-3A BR0317748A BR0317748A BR 0317748 A BR0317748 A BR 0317748A BR 0317748 A BR0317748 A BR 0317748A BR 0317748 A BR0317748 A BR 0317748A
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
pharmaceutically acceptable
general formula
acceptable salts
Prior art date
Application number
BR0317748-3A
Other languages
Portuguese (pt)
Inventor
Mario Rottlonder
Ritzen Andreas
Morten Bang Norgaard
Nikolay Khanzhin
Christian Wenzel Tornoe
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0317748(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority claimed from PCT/DK2003/000906 external-priority patent/WO2004058739A1/en
Publication of BR0317748A publication Critical patent/BR0317748A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, USO DE UM COMPOSTO". A presente invenção refere-se aos derivados de 1,2,4-triamino-benzeno de fórmula geral I ou aos seus sais farmaceuticamente aceitáveis e ao seu uso."COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE OF A COMPOUND". The present invention relates to the 1,2,4-triamino benzene derivatives of general formula I or their pharmaceutically acceptable salts and their use.

BR0317748-3A 2002-12-27 2003-12-18 Compound, pharmaceutical composition, and use of a compound BR0317748A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202012 2002-12-27
PCT/DK2003/000906 WO2004058739A1 (en) 2002-12-27 2003-12-18 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Publications (1)

Publication Number Publication Date
BR0317748A true BR0317748A (en) 2005-11-22

Family

ID=35295526

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317748-3A BR0317748A (en) 2002-12-27 2003-12-18 Compound, pharmaceutical composition, and use of a compound

Country Status (17)

Country Link
KR (1) KR20050089862A (en)
CN (1) CN100448867C (en)
AR (1) AR042656A1 (en)
BR (1) BR0317748A (en)
CL (1) CL2003002748A1 (en)
EA (1) EA008589B1 (en)
HK (1) HK1088317A1 (en)
IS (1) IS2649B (en)
MY (1) MY139844A (en)
NO (1) NO20053612L (en)
PE (1) PE20041015A1 (en)
PL (1) PL377221A1 (en)
SI (1) SI1578740T1 (en)
TW (1) TWI325414B (en)
UA (1) UA79666C2 (en)
UY (1) UY28151A1 (en)
ZA (1) ZA200504565B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (en) * 1992-01-08 1993-07-15 Asta Medica Ag NEW 1,2,4-TRIAMINOBENZOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DE19539861A1 (en) * 1995-10-26 1997-04-30 Asta Medica Ag Use of 4-amino-4- (4-fluorobenzylamino) -1-ethoxy-carbonylaminobenzen for the prophylaxis and treatment of the consequences of acute and chronic cerebral low blood circulation and neurodegenerative diseases
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
US6117900A (en) * 1999-09-27 2000-09-12 Asta Medica Aktiengesellschaft Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) * 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders

Also Published As

Publication number Publication date
CN100448867C (en) 2009-01-07
TWI325414B (en) 2010-06-01
NO20053612D0 (en) 2005-07-25
IS2649B (en) 2010-08-15
PE20041015A1 (en) 2005-01-08
IS7856A (en) 2005-05-23
UY28151A1 (en) 2004-07-30
EA008589B1 (en) 2007-06-29
KR20050089862A (en) 2005-09-08
AR042656A1 (en) 2005-06-29
HK1088317A1 (en) 2006-11-03
MY139844A (en) 2009-11-30
TW200413280A (en) 2004-08-01
SI1578740T1 (en) 2007-08-31
ZA200504565B (en) 2006-08-30
PL377221A1 (en) 2006-01-23
UA79666C2 (en) 2007-07-10
NO20053612L (en) 2005-09-23
CL2003002748A1 (en) 2005-04-08
CN1732162A (en) 2006-02-08
EA200501053A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
BRPI0408437A (en) substituted p-diaminobenzene derivatives, pharmaceutical composition, and use thereof
BR0108893A (en) Pharmaceutical composition, compound and compound preparation process
BR0111263A (en) 2-Aminocarbonyl-9h-purine derivatives
BR0307267A (en) Heterocyclic compounds, active as inhibitors of beta-lactams
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
BRPI0508570A (en) compound, pharmaceutical composition, and use thereof
DK2314582T3 (en) Heterocyclic compounds as antiviral agents
BRPI0413469A (en) piperazine derivatives for the treatment of hiv infections
GB0206860D0 (en) Compounds
BR0112395A (en) Benzothiazole Derivatives
BR9917080A (en) Compound, pharmaceutical composition, use of the compound and method of treatment or prevention of thromboembolic dysfunction
BRPI0212726B8 (en) compounds containing lactams, and derivatives thereof, pharmaceutical composition comprising them and their uses
BR0206695A (en) Epothilone oral dosage forms
BRPI0213063B8 (en) dual-action antibiotic compound, its pharmaceutical composition and its use
BR0212069A (en) Oral antidiabetic agents
BRPI0409465A (en) carboxamide derivatives as antidiabetic agents
BR0113590A (en) 7-oxopyridopyrimidines
BR9905089A (en) Macrolide derivatives
BR0101230A (en) Process for the preparation of 11-amino-3-chloro-6,11-dihydro-5-5-dioxo-6-methyl-dibenzo [c, f] [1,2] thiazepine and application for the synthesis of detianeptine
BRPI0408205A (en) substituted aniline derivative, pharmaceutical composition, and, use of a pharmaceutical composition
TR200000153T2 (en) 6-azauracil derivatives that inhibit il-5.
BR0212031A (en) Combination preparations of 1-4-benzothiepine 1,1-dioxide derivatives with other active substances and their use
BR0015333A (en) Isoxazole derivatives as phosphodiesterase inhibitors vii
BRPI0406704A (en) 5ht ~ 7 ~ Antagonists and Inverse Agonists
BR0315106A (en) Antimicrobial derivatives of [3.1.0] bicyclic oxazolidinone

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.